Wnt signaling in cancer pathogenesis and therapeutics

Naoko Takebe, Lawrence Lum, S. Percy Ivy

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

This chapter presents a concise review of Wnt signaling in cancer pathogenesis. Our focus is on the description of novel agents in preclinical and/or clinical stage development, which inhibit dysfunctional Wnt signaling. We discuss growing evidence that the Wnt pathway supports cellular proliferation by sustaining renewal of cancer initiating stem cells. We also review ongoing therapeutic efforts to inhibit pathway activity in a broad range of cancers. The rationale for targeting this pathway is well justified, based on the association of colorectal cancer with deregulation of Wnt signaling. Therefore, the Wnt pathway may represent an important target for the development of novel anticancer therapeutics.

Original languageEnglish (US)
Title of host publicationSignaling Pathways in Cancer Pathogenesis and Therapy
PublisherSpringer New York
Pages81-94
Number of pages14
ISBN (Electronic)9781461412168
ISBN (Print)1461412153, 9781461412151
DOIs
StatePublished - Aug 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Wnt signaling in cancer pathogenesis and therapeutics'. Together they form a unique fingerprint.

Cite this